{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T03:56:20Z","timestamp":1772078180411,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007835","name":"Wenzhou Medical University","doi-asserted-by":"crossref","award":["K171202"],"award-info":[{"award-number":["K171202"]}],"id":[{"id":"10.13039\/100007835","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Zhejiang Provincial Natural Science Foundation, China","award":["LY18H120003"],"award-info":[{"award-number":["LY18H120003"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.exer.2019.03.018","type":"journal-article","created":{"date-parts":[[2019,3,24]],"date-time":"2019-03-24T10:23:37Z","timestamp":1553423017000},"page":"93-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Intravenous injection of l-aspartic acid \u03b2-hydroxamate attenuates choroidal neovascularization via anti-VEGF and anti-inflammation"],"prefix":"10.1016","volume":"182","author":[{"given":"Mengjuan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiling","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3561-2088","authenticated-orcid":false,"given":"Ge","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1154-2369","authenticated-orcid":false,"given":"Shengzhou","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2019.03.018_bib1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1006\/bbrc.1993.1671","article-title":"Synthesis and secretion of vascular permeability factor\/vascular endothelial growth factor by human retinal pigment epithelial cells","volume":"193","author":"Adamis","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exer.2019.03.018_bib2","doi-asserted-by":"crossref","first-page":"E2400","DOI":"10.1073\/pnas.1304308110","article-title":"Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction","volume":"110","author":"Balu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2019.03.018_bib3","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.15252\/embj.201694202","article-title":"The retinal pigment epithelium as a gateway for monocyte trafficking into the eye","volume":"35","author":"Benhar","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.exer.2019.03.018_bib4","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0002-9440(10)65138-3","article-title":"Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation","volume":"155","author":"Blaauwgeers","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2019.03.018_bib5","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1073\/pnas.0438014100","article-title":"Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration","volume":"100","author":"Bora","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2019.03.018_bib6","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1167\/iovs.13-13654","article-title":"AAV-mediated lysophosphatidylcholine acyltransferase 1 (Lpcat1) gene replacement therapy rescues retinal degeneration in rd11 mice","volume":"55","author":"Dai","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.03.018_bib7","first-page":"819","article-title":"Monocyte chemotactic protein gene expression by cytokine-treated human retinal pigment epithelial cells","volume":"64","author":"Elner","year":"1991","journal-title":"Lab. Invest."},{"key":"10.1016\/j.exer.2019.03.018_bib8","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1167\/iovs.03-0038","article-title":"Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization","volume":"44","author":"Espinosa-Heidmann","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.03.018_bib9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye"},{"key":"10.1016\/j.exer.2019.03.018_bib10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/0003-2697(79)90050-2","article-title":"Phenazine ethosulfate as a preferred electron acceptor to phenazine methosulfate in dye-linked enzyme assays","volume":"99","author":"Ghosh","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.exer.2019.03.018_bib11","first-page":"119","article-title":"Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization","volume":"8","author":"Grossniklaus","year":"2002","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2019.03.018_bib12","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0014-4835(03)00189-1","article-title":"Retinal pigment epithelium and endothelial cell interaction causes retinal pigment epithelial barrier dysfunction via a soluble VEGF-dependent mechanism","volume":"77","author":"Hartnett","year":"2003","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2019.03.018_bib13","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","article-title":"Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration","volume":"119","author":"Heier","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2019.03.018_bib14","doi-asserted-by":"crossref","first-page":"6032","DOI":"10.1021\/jm900775q","article-title":"Hydroxamic acids as a novel family of serine racemase inhibitors: mechanistic analysis reveals different modes of interaction with the pyridoxal-5'-phosphate cofactor","volume":"52","author":"Hoffman","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.exer.2019.03.018_bib15","doi-asserted-by":"crossref","first-page":"14486","DOI":"10.1523\/JNEUROSCI.5034-08.2008","article-title":"NMDA- and beta-amyloid1-42-induced neurotoxicity is attenuated in serine racemase knock-out mice","volume":"28","author":"Inoue","year":"2008","journal-title":"J. Neurosci. : Off. J. Soc. Neurosci."},{"key":"10.1016\/j.exer.2019.03.018_bib16","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.exer.2018.06.017","article-title":"Loss-of-function mutation of serine racemase attenuates retinal ganglion cell loss in diabetic mice","volume":"175","author":"Jiang","year":"2018","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2019.03.018_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1742-2094-8-119","article-title":"Overexpression of serine racemase in retina and overproduction of D-serine in eyes of streptozotocin-induced diabetic retinopathy","volume":"8","author":"Jiang","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.exer.2019.03.018_bib18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/jnc.13400","article-title":"Loss-of-function mutation of serine racemase attenuates excitotoxicity by intravitreal injection of N-methyl-D-aspartate","volume":"136","author":"Jiang","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.exer.2019.03.018_bib19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/jnc.14214","article-title":"Serine racemase deficiency attenuates choroidal neovascularization and reduces nitric oxide and VEGF levels by retinal pigment epithelial cells","volume":"143","author":"Jiang","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.exer.2019.03.018_bib20","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/hmg\/ddp261","article-title":"Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model","volume":"18","author":"Labrie","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.exer.2019.03.018_bib21","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1021\/jf035493g","article-title":"Monohydroxamates of aspartic acid and glutamic acid exhibit antioxidant and angiotensin converting enzyme inhibitory activities","volume":"52","author":"Liu","year":"2004","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.exer.2019.03.018_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/IAE.0b013e3182657fff","article-title":"Retinal pigment epithelial atrophy in patients with exudative age-related macular degeneration undergoing anti-vascular endothelial growth factor therapy","volume":"33","author":"Lois","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.exer.2019.03.018_bib23","first-page":"855","article-title":"Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes","volume":"37","author":"Lopez","year":"1996","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.03.018_bib24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/jnc.13970","article-title":"Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-d-aspartate-induced excitotoxicity","volume":"141","author":"Luo","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.exer.2019.03.018_bib25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/mp.2012.97","article-title":"Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion","volume":"18","author":"Ma","year":"2013","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.exer.2019.03.018_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.52","article-title":"d-serine levels in Alzheimer's disease: implications for novel biomarker development","volume":"5","author":"Madeira","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.exer.2019.03.018_bib27","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1016\/j.bmc.2017.05.011","article-title":"A novel serine racemase inhibitor suppresses neuronal over-activation in vivo","volume":"25","author":"Mori","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.exer.2019.03.018_bib28","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1523\/JNEUROSCI.4297-09.2010","article-title":"Serine racemase deletion protects against cerebral ischemia and excitotoxicity","volume":"30","author":"Mustafa","year":"2010","journal-title":"J. Neurosci. : Off. J. Soc. Neurosci."},{"key":"10.1016\/j.exer.2019.03.018_bib29","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1167\/iovs.06-1296","article-title":"Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin","volume":"48","author":"Nagai","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.03.018_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1196\/annals.1348.062","article-title":"Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseases","volume":"1082","author":"Ng","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.exer.2019.03.018_bib31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","article-title":"Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury","volume":"171","author":"Nishijima","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2019.03.018_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190864","article-title":"Serine racemase deletion attenuates neurodegeneration and microvascular damage in diabetic retinopathy","volume":"13","author":"Ozaki","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2019.03.018_bib33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ajo.2007.10.004","article-title":"Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1","volume":"145","author":"Regillo","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2019.03.018_bib34","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2019.03.018_bib35","doi-asserted-by":"crossref","first-page":"18751","DOI":"10.1073\/pnas.0905010106","article-title":"An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris","volume":"106","author":"Saint-Geniez","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2019.03.018_bib36","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1182\/blood.V97.4.1009","article-title":"Accumulation of HIF-1 alpha under the influence of nitric oxide","volume":"97","author":"Sandau","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exer.2019.03.018_bib37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/bbrc.2000.3789","article-title":"Induction of hypoxia-inducible-factor 1 by nitric oxide is mediated via the PI 3K pathway","volume":"278","author":"Sandau","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exer.2019.03.018_bib38","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1073\/pnas.1237052100","article-title":"D-serine and serine racemase are present in the vertebrate retina and contribute to the physiological activation of NMDA receptors","volume":"100","author":"Stevens","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2019.03.018_bib39","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.neurobiolaging.2009.09.001","article-title":"Reduced serine racemase expression contributes to age-related deficits in hippocampal cognitive function","volume":"32","author":"Turpin","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.exer.2019.03.018_bib40","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1167\/iovs.16-19691","article-title":"Thy-1 regulates VEGF-mediated choroidal endothelial cell activation and migration: implications in neovascular age-related macular degeneration","volume":"57","author":"Wang","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2019.03.018_bib41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neuroscience.2016.09.036","article-title":"Serine racemase inhibition induces nitric oxide-mediated neurovascular protection during cerebral ischemia","volume":"339","author":"Watanabe","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.exer.2019.03.018_bib42","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-2094-1-2","article-title":"Induction of serine racemase expression and D-serine release from microglia by amyloid beta-peptide","volume":"1","author":"Wu","year":"2004","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.exer.2019.03.018_bib43","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/jnr.20401","article-title":"Schwann cells exhibit excitotoxicity consistent with release of NMDA receptor agonists","volume":"79","author":"Wu","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.exer.2019.03.018_bib44","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3928\/23258160-20150304-01","article-title":"Comparing aflibercept, bevacizumab, and ranibizumab for DME: analysis of DRCR Protocol T","volume":"46","author":"Wykoff","year":"2015","journal-title":"Ophthalmic Surg. Laser. Imag. Retina"},{"key":"10.1016\/j.exer.2019.03.018_bib45","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/jnc.13663","article-title":"DISC1, astrocytes and neuronal maturation: a possible mechanistic link with implications for mental disorders","volume":"138","author":"Xia","year":"2016","journal-title":"J. Neurochem."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483519300120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483519300120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:59:54Z","timestamp":1757998794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483519300120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":45,"alternative-id":["S0014483519300120"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2019.03.018","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous injection of l-aspartic acid \u03b2-hydroxamate attenuates choroidal neovascularization via anti-VEGF and anti-inflammation","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2019.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}